Alucent Biomedical
Salt Lake City, UT
Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. The therapy focuses on peripheral artery disease (PAD), arteriovenous fistula (AVF) maturation for dialysis, and more.
alucentmedical.comCompany Details
Founded
- 2017
Employees
- Between 20 - 50 employees
Raised
- $46,600,000
Headquarters Location
- Salt Lake City, UT
Public
- No
Acquired
- No
CEO
Myles Greenberg
Founders
- Ron Utecht
Company Collections
These are collections Alucent Biomedical is a part of. Click on the collection name to view similar companies.
Alucent Biomedical's Industries
Alucent Biomedical Headquarters Location
Total Amount Raised: $46,600,000
Alucent Biomedical Funding Rounds
Series Unknown
$11,200,000
Series B
$34,999,999
Seed
$400,000
Alucent Biomedical Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Alucent Biomedical.